LDL oxidation and extent of coronary atherosclerosis. 1998

L P van de Vijver, and A F Kardinaal, and W van Duyvenvoorde, and D A Kruijssen, and D E Grobbee, and G van Poppel, and H M Princen
Department of Consumer Research and Epidemiology, Dutch Organization for Applied Scientific Research Nutrition and Food Research Institute, Zeist, The Netherlands.

Accumulated evidence indicates that oxidative modification of LDL plays an important role in the atherogenic process. Therefore, we investigated the relation between coronary atherosclerosis and susceptibility of LDL to oxidation in a case-control study in men between 45 and 80 years of age. Case subjects and hospital control subjects were selected from subjects undergoing a first coronary angiography. Subjects with severe coronary stenosis (> or = 85% stenosis in one and > or = 50% stenosis in a second major coronary vessel) were classified as case subjects (n=91). Hospital control subjects with no or minor stenosis (< or = 50% stenosis in no more than two of the three major coronary vessels, n=94) and population control subjects free of plaques in the carotid artery (n=85) were pooled for the statistical analysis into one control category. Enrollment procedures allowed for similar distributions in age and smoking habits. Case subjects had higher levels of total and LDL cholesterol and triglycerides and lower levels of HDL cholesterol. Resistance time, maximum rate of oxidation, and maximum diene production were measured ex vivo using copper-induced LDL oxidation. A borderline significant inverse trend was observed for coronary atherosclerosis risk at increasing resistance time. Odds ratios (95% confidence interval) for the successive quartiles were 1.0 (reference), 0.77 (0.39 to 1.53), 0.67 (0.33 to 1.34), and 0.55 (0.27 to 1.15) (ptrend=0.07). No relation with maximum rate of oxidation was found, and higher maximum diene levels were found in control subjects (P<.01). The main determinant of oxidation was the fatty acid composition of LDL. No effect of smoking or use of medication was observed. We conclude that although LDL resistance to oxidation may be a factor in atherogenesis, the ex vivo measure is not a strong predictor of severity of coronary atherosclerosis.

UI MeSH Term Description Entries
D008074 Lipoproteins Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes. Circulating Lipoproteins,Lipoprotein,Lipoproteins, Circulating
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D003324 Coronary Artery Disease Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause. Arteriosclerosis, Coronary,Atherosclerosis, Coronary,Coronary Arteriosclerosis,Coronary Atherosclerosis,Left Main Coronary Artery Disease,Left Main Coronary Disease,Left Main Disease,Arterioscleroses, Coronary,Artery Disease, Coronary,Artery Diseases, Coronary,Atheroscleroses, Coronary,Coronary Arterioscleroses,Coronary Artery Diseases,Coronary Atheroscleroses,Left Main Diseases
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

L P van de Vijver, and A F Kardinaal, and W van Duyvenvoorde, and D A Kruijssen, and D E Grobbee, and G van Poppel, and H M Princen
July 1992, Lancet (London, England),
L P van de Vijver, and A F Kardinaal, and W van Duyvenvoorde, and D A Kruijssen, and D E Grobbee, and G van Poppel, and H M Princen
July 1992, Lancet (London, England),
L P van de Vijver, and A F Kardinaal, and W van Duyvenvoorde, and D A Kruijssen, and D E Grobbee, and G van Poppel, and H M Princen
July 1992, Lancet (London, England),
L P van de Vijver, and A F Kardinaal, and W van Duyvenvoorde, and D A Kruijssen, and D E Grobbee, and G van Poppel, and H M Princen
January 1991, Duodecim; laaketieteellinen aikakauskirja,
L P van de Vijver, and A F Kardinaal, and W van Duyvenvoorde, and D A Kruijssen, and D E Grobbee, and G van Poppel, and H M Princen
December 2003, Archives of biochemistry and biophysics,
L P van de Vijver, and A F Kardinaal, and W van Duyvenvoorde, and D A Kruijssen, and D E Grobbee, and G van Poppel, and H M Princen
January 2015, Inflammatory bowel diseases,
L P van de Vijver, and A F Kardinaal, and W van Duyvenvoorde, and D A Kruijssen, and D E Grobbee, and G van Poppel, and H M Princen
January 1994, Advances in experimental medicine and biology,
L P van de Vijver, and A F Kardinaal, and W van Duyvenvoorde, and D A Kruijssen, and D E Grobbee, and G van Poppel, and H M Princen
February 2001, Current opinion in lipidology,
L P van de Vijver, and A F Kardinaal, and W van Duyvenvoorde, and D A Kruijssen, and D E Grobbee, and G van Poppel, and H M Princen
May 2002, Annals of the New York Academy of Sciences,
L P van de Vijver, and A F Kardinaal, and W van Duyvenvoorde, and D A Kruijssen, and D E Grobbee, and G van Poppel, and H M Princen
February 2001, The Journal of nutrition,
Copied contents to your clipboard!